| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta | 10 | 2021 | 540 | 1.750 |
Why?
|
| Aging | 12 | 2023 | 1164 | 0.980 |
Why?
|
| Blood Flow Velocity | 14 | 2021 | 447 | 0.930 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2010 | 222 | 0.830 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2009 | 117 | 0.810 |
Why?
|
| Myocardial Contraction | 2 | 2021 | 261 | 0.750 |
Why?
|
| Vascular Stiffness | 3 | 2023 | 75 | 0.750 |
Why?
|
| Ventricular Function, Left | 3 | 2021 | 500 | 0.720 |
Why?
|
| Echocardiography, Doppler, Pulsed | 3 | 2021 | 19 | 0.700 |
Why?
|
| Vascular Resistance | 4 | 2009 | 188 | 0.690 |
Why?
|
| Mice | 44 | 2023 | 17430 | 0.620 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 2 | 2009 | 25 | 0.550 |
Why?
|
| Hemorheology | 3 | 2005 | 28 | 0.530 |
Why?
|
| Pulsatile Flow | 7 | 2011 | 133 | 0.510 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2016 | 242 | 0.510 |
Why?
|
| Heart | 6 | 2023 | 725 | 0.440 |
Why?
|
| Animals | 49 | 2023 | 33618 | 0.440 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 338 | 0.440 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.430 |
Why?
|
| Growth Hormone | 1 | 2013 | 149 | 0.420 |
Why?
|
| Transducers | 2 | 2009 | 25 | 0.410 |
Why?
|
| Isoflurane | 3 | 2009 | 45 | 0.400 |
Why?
|
| Hypertension | 6 | 2023 | 1276 | 0.350 |
Why?
|
| Argininosuccinic Aciduria | 3 | 2018 | 47 | 0.350 |
Why?
|
| Ultrasonography, Doppler | 9 | 2015 | 197 | 0.340 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 46 | 0.310 |
Why?
|
| Myocardium | 6 | 2023 | 982 | 0.290 |
Why?
|
| Ventricular Function | 1 | 2008 | 93 | 0.280 |
Why?
|
| Blood Pressure Determination | 2 | 2008 | 105 | 0.270 |
Why?
|
| Argininosuccinate Lyase | 3 | 2018 | 59 | 0.270 |
Why?
|
| Myocytes, Cardiac | 4 | 2017 | 617 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 4323 | 0.260 |
Why?
|
| Vasodilator Agents | 4 | 2013 | 203 | 0.250 |
Why?
|
| Biomedical Engineering | 3 | 2017 | 30 | 0.250 |
Why?
|
| Equipment Design | 6 | 2015 | 598 | 0.240 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 127 | 0.240 |
Why?
|
| Tissue Engineering | 2 | 2017 | 177 | 0.240 |
Why?
|
| Coronary Circulation | 4 | 2010 | 209 | 0.230 |
Why?
|
| Disease Models, Animal | 13 | 2018 | 4257 | 0.230 |
Why?
|
| Aortic Valve Stenosis | 2 | 2005 | 322 | 0.230 |
Why?
|
| Nitric Oxide | 5 | 2018 | 432 | 0.230 |
Why?
|
| Equipment Failure Analysis | 4 | 2009 | 89 | 0.230 |
Why?
|
| Mitochondria | 3 | 2023 | 681 | 0.220 |
Why?
|
| Mice, Knockout | 13 | 2016 | 3710 | 0.220 |
Why?
|
| Ventricular Remodeling | 4 | 2008 | 175 | 0.220 |
Why?
|
| Arteries | 3 | 2023 | 222 | 0.220 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2018 | 31 | 0.200 |
Why?
|
| Blood Pressure | 7 | 2018 | 1309 | 0.200 |
Why?
|
| Mice, Mutant Strains | 4 | 2013 | 381 | 0.200 |
Why?
|
| Myocardial Infarction | 4 | 2013 | 997 | 0.190 |
Why?
|
| Cardiomegaly | 3 | 2008 | 133 | 0.190 |
Why?
|
| Acceleration | 1 | 2021 | 27 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 359 | 0.180 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 43 | 0.180 |
Why?
|
| Dobutamine | 1 | 2021 | 56 | 0.180 |
Why?
|
| Middle Cerebral Artery | 2 | 2013 | 110 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 165 | 0.180 |
Why?
|
| Vasodilation | 2 | 2013 | 191 | 0.180 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2011 | 31 | 0.180 |
Why?
|
| Echocardiography | 4 | 2016 | 1069 | 0.170 |
Why?
|
| Apolipoproteins E | 5 | 2016 | 190 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2011 | 848 | 0.160 |
Why?
|
| Carotid Arteries | 3 | 2004 | 151 | 0.160 |
Why?
|
| Diet Therapy | 1 | 2018 | 42 | 0.150 |
Why?
|
| Acetylcysteine | 1 | 2018 | 73 | 0.150 |
Why?
|
| Bioartificial Organs | 1 | 2017 | 11 | 0.150 |
Why?
|
| Coronary Vessels | 4 | 2010 | 524 | 0.150 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 232 | 0.150 |
Why?
|
| Glycine | 1 | 2018 | 160 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 481 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 74 | 0.140 |
Why?
|
| Heart, Artificial | 1 | 2017 | 69 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2018 | 528 | 0.140 |
Why?
|
| Action Potentials | 2 | 2017 | 498 | 0.140 |
Why?
|
| Glycosphingolipids | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 1834 | 0.130 |
Why?
|
| Fibrosis | 4 | 2022 | 429 | 0.130 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2016 | 41 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2013 | 831 | 0.130 |
Why?
|
| Arterial Pressure | 2 | 2014 | 104 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 60 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2016 | 828 | 0.130 |
Why?
|
| Heart Failure, Diastolic | 1 | 2015 | 11 | 0.130 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 27 | 0.130 |
Why?
|
| Heart Rate | 3 | 2014 | 584 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2017 | 961 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 119 | 0.120 |
Why?
|
| Genetic Therapy | 2 | 2012 | 661 | 0.120 |
Why?
|
| Mole Rats | 1 | 2014 | 1 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2018 | 462 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 514 | 0.120 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2015 | 58 | 0.120 |
Why?
|
| Myocarditis | 2 | 2013 | 119 | 0.120 |
Why?
|
| Male | 14 | 2023 | 59714 | 0.110 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2013 | 5 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2016 | 333 | 0.110 |
Why?
|
| Collagen | 4 | 2022 | 312 | 0.110 |
Why?
|
| Heart Atria | 1 | 2015 | 310 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 2528 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 239 | 0.110 |
Why?
|
| Phenotype | 5 | 2022 | 4200 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2013 | 196 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 286 | 0.100 |
Why?
|
| Diastole | 3 | 2015 | 170 | 0.100 |
Why?
|
| Mitochondrial Proteins | 2 | 2023 | 237 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 439 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2009 | 2821 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2023 | 4503 | 0.090 |
Why?
|
| Female | 11 | 2022 | 65117 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 2017 | 0.090 |
Why?
|
| Thrombosis | 1 | 2016 | 517 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2011 | 52 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 214 | 0.090 |
Why?
|
| Basilar Artery | 1 | 2010 | 25 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 2047 | 0.090 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2010 | 19 | 0.090 |
Why?
|
| Blood Volume | 1 | 2010 | 80 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2012 | 263 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 199 | 0.090 |
Why?
|
| Pulse Wave Analysis | 2 | 2023 | 47 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 73 | 0.080 |
Why?
|
| Potassium | 1 | 2010 | 278 | 0.080 |
Why?
|
| Body Weight | 3 | 2010 | 959 | 0.080 |
Why?
|
| Species Specificity | 2 | 2008 | 547 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2009 | 50 | 0.080 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2008 | 4 | 0.080 |
Why?
|
| Algorithms | 2 | 2005 | 1583 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2009 | 147 | 0.080 |
Why?
|
| Inflammation | 3 | 2018 | 1398 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2008 | 61 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2008 | 141 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2007 | 54 | 0.070 |
Why?
|
| Age Factors | 2 | 2014 | 2788 | 0.070 |
Why?
|
| Dwarfism | 1 | 2007 | 101 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 423 | 0.070 |
Why?
|
| Exercise Test | 1 | 2007 | 250 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 2391 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 52 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2018 | 3047 | 0.060 |
Why?
|
| Regional Blood Flow | 3 | 2011 | 210 | 0.060 |
Why?
|
| Motion | 1 | 2004 | 44 | 0.060 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 31 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2003 | 944 | 0.060 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 632 | 0.050 |
Why?
|
| Tail | 1 | 2003 | 16 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 1209 | 0.050 |
Why?
|
| Elasticity | 1 | 2003 | 92 | 0.050 |
Why?
|
| Heart Failure | 2 | 2013 | 2123 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2008 | 765 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2018 | 796 | 0.050 |
Why?
|
| Systole | 1 | 2003 | 197 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 37 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 262 | 0.050 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2022 | 24 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 211 | 0.050 |
Why?
|
| Models, Cardiovascular | 3 | 2011 | 178 | 0.050 |
Why?
|
| Time Factors | 3 | 2017 | 6188 | 0.050 |
Why?
|
| Organ Size | 3 | 2010 | 411 | 0.050 |
Why?
|
| Vasoconstriction | 2 | 2011 | 104 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 138 | 0.040 |
Why?
|
| Arginine | 2 | 2012 | 298 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 2011 | 137 | 0.040 |
Why?
|
| Heart Sounds | 1 | 1999 | 9 | 0.040 |
Why?
|
| Poultry Diseases | 1 | 1999 | 7 | 0.040 |
Why?
|
| Phonocardiography | 1 | 1999 | 6 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 354 | 0.040 |
Why?
|
| Diet | 1 | 2006 | 1107 | 0.040 |
Why?
|
| rho-Associated Kinases | 2 | 2011 | 55 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1683 | 0.040 |
Why?
|
| Calcium | 2 | 2013 | 1096 | 0.040 |
Why?
|
| Gels | 1 | 2017 | 60 | 0.040 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 77 | 0.040 |
Why?
|
| Chemokines | 2 | 2008 | 137 | 0.040 |
Why?
|
| Fibrin | 1 | 2017 | 67 | 0.040 |
Why?
|
| Hypoxia | 1 | 1999 | 245 | 0.040 |
Why?
|
| Rats | 2 | 2015 | 3620 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2018 | 159 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 240 | 0.040 |
Why?
|
| Glutathione | 1 | 2018 | 193 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 101 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 159 | 0.030 |
Why?
|
| Antioxidants | 1 | 2018 | 337 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2011 | 876 | 0.030 |
Why?
|
| Obesity | 1 | 2006 | 2091 | 0.030 |
Why?
|
| Electrodes | 1 | 2015 | 97 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 327 | 0.030 |
Why?
|
| Compliance | 1 | 2014 | 17 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 198 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2014 | 16 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 277 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 988 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2013 | 13 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 23 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 137 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 47 | 0.030 |
Why?
|
| Biological Factors | 1 | 2013 | 28 | 0.030 |
Why?
|
| Longevity | 1 | 2014 | 120 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2013 | 95 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 312 | 0.030 |
Why?
|
| Humans | 7 | 2023 | 122633 | 0.030 |
Why?
|
| Mitral Valve | 2 | 2008 | 246 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 230 | 0.030 |
Why?
|
| Respiration | 1 | 2013 | 123 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 422 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 2012 | 30 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 37 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 218 | 0.030 |
Why?
|
| Genotype | 2 | 2010 | 2531 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1736 | 0.020 |
Why?
|
| Argininosuccinate Synthase | 1 | 2011 | 20 | 0.020 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2011 | 6 | 0.020 |
Why?
|
| Calcium Channel Agonists | 1 | 2011 | 12 | 0.020 |
Why?
|
| Nitrites | 1 | 2011 | 41 | 0.020 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2011 | 39 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2011 | 54 | 0.020 |
Why?
|
| Trachea | 1 | 2013 | 201 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 2011 | 13 | 0.020 |
Why?
|
| Miniaturization | 1 | 2011 | 27 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 515 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 333 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 185 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 350 | 0.020 |
Why?
|
| alpha-Linolenic Acid | 1 | 2010 | 15 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2011 | 304 | 0.020 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 23 | 0.020 |
Why?
|
| Sleep | 1 | 2013 | 346 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2100 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2010 | 70 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 88 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2010 | 82 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2010 | 44 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 789 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 32 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 662 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 114 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 171 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2009 | 57 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 160 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1164 | 0.020 |
Why?
|
| Swine | 1 | 2011 | 1154 | 0.020 |
Why?
|
| Hyperemia | 1 | 2008 | 25 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 65 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 70 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 679 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2007 | 22 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2010 | 448 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2007 | 49 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 2007 | 73 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 18987 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 753 | 0.020 |
Why?
|
| Anesthetics | 1 | 2008 | 81 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 233 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2774 | 0.020 |
Why?
|
| Pressure | 1 | 2006 | 130 | 0.020 |
Why?
|
| Models, Animal | 1 | 2008 | 463 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1610 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 1102 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1758 | 0.020 |
Why?
|
| Mifepristone | 1 | 2005 | 137 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2005 | 92 | 0.020 |
Why?
|
| Neutrophils | 1 | 2007 | 372 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 256 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 1725 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 516 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 456 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 144 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2008 | 425 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 366 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1684 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 607 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 136 | 0.010 |
Why?
|
| Constriction | 1 | 2003 | 48 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 132 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 552 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 308 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 1992 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 604 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 743 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 341 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 924 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 2815 | 0.010 |
Why?
|
| Ultrasonics | 1 | 2000 | 37 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1568 | 0.010 |
Why?
|
| Hematocrit | 1 | 2000 | 110 | 0.010 |
Why?
|
| Acclimatization | 1 | 1999 | 15 | 0.010 |
Why?
|
| Anesthesia | 1 | 2002 | 209 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 636 | 0.010 |
Why?
|
| Child | 1 | 2018 | 24086 | 0.010 |
Why?
|
| Cholesterol | 1 | 2000 | 518 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 298 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1999 | 373 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 13794 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1999 | 429 | 0.010 |
Why?
|